BIOCRYST PHARMACEUTICALS INC

Federal contract awards won by BIOCRYST PHARMACEUTICALS INC (UEI MGXADJ6SCLJ5), 2013–2025 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

11
awards
0
expiring in 12 months
2
agencies

Awards

PHARM - ORLADEYO
Department of Veterans Affairs · $360,000 · Oct 1, 2025
BULK ORDER ORLADEYO FOR VETERAN CARE.
Department of Veterans Affairs · $382,301 · Sep 9, 2025
BULK ORLADEYO PHARMACEUTICAL
Department of Veterans Affairs · $394,853 · Mar 12, 2025
BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).
Department of Veterans Affairs · $379,939 · Oct 1, 2024
PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))
Department of Health and Human Services · $13,877,674 · Sep 30, 2024
BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP
Department of Veterans Affairs · $374,626 · Sep 9, 2024
BULK ORDER ORLADEYO
Department of Veterans Affairs · $385,448 · Mar 12, 2024
BEROTRALSTAT HCL 150MG CAP,ORAL BULK, 72769-0101-01
Department of Veterans Affairs · $368,683 · Jun 1, 2022
PERAMIVIR, RAPIVAB FLU TREATMENT
Department of Health and Human Services · $34,660,000 · Sep 1, 2018